BRIEF-Rhinomed Ltd says raises A$2.5 mln

Thu, 20 Feb - 8:33am

Feb 20 (Reuters) - Rhinomed Ltd RNO.AX :

* Raises A$2.5 million to accelerate drug delivery program

* Placement of 60 million new fully paid ordinary shares at an issue price of

A$0.042 per share

* "Funds raised enables the company to accelerate the drug delivery program

focused on the delivery of sumatriptan using the breatheassist technology

platform"

* Source text for Eikon News Search ID:nASX7HNZMn

((For more news, please click here RNO.AX )) ((Bangalore Newsroom; +91 80 6749 1130))

URN: 
urn:newsml:reuters.com:20140219:nWNBS00BXV:5
Topics: 
HLTH AU CMPNY HECA ASIA BLR DBT LOA LEN HPRD RTRS CDM CORPD PHMR MEDQ DRU

Contact Us

Due to the security nature of our business, personal meetings are only by pre-arranged appointment.
Phone at any time on

1300 987 995

info@ausmint.com